News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,860 Results
Type
Article (43551)
Company Profile (234)
Press Release (696064)
Multimedia
Podcasts (122)
Webinars (21)
Section
Business (205876)
Career Advice (2040)
Deals (35790)
Drug Delivery (139)
Drug Development (82655)
Employer Resources (173)
FDA (16658)
Job Trends (15061)
News (349298)
Policy (33200)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2645)
Accelerated approval (55)
ADA (44)
Adcomms (30)
Allergies (195)
Alliances (49976)
ALS (226)
Alzheimer's disease (1850)
Antibody-drug conjugate (ADC) (520)
Approvals (17125)
Artificial intelligence (730)
ASCO (328)
Autoimmune disease (348)
Automation (63)
Bankruptcy (366)
Best Places to Work (11672)
BIO (70)
BIOSECURE Act (20)
Biosimilars (235)
Biotechnology (150)
Bladder cancer (205)
Brain cancer (76)
Breast cancer (804)
Cancer (6346)
Cardiovascular disease (507)
Career advice (1738)
Career pathing (45)
CAR-T (356)
CDC (73)
Celiac Disease (3)
Cell therapy (970)
Cervical cancer (56)
Clinical research (72207)
Collaboration (2218)
Commercialization (1)
Company closure (6)
Compensation (1521)
Complete response letters (86)
COVID-19 (2971)
CRISPR (117)
C-suite (1251)
Cystic fibrosis (160)
Data (8676)
Decentralized trials (3)
Denatured (32)
Depression (175)
Dermatology (98)
Diabetes (668)
Diagnostics (7043)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (367)
Drug pricing (204)
Drug shortages (31)
Duchenne muscular dystrophy (310)
Earnings (92392)
Editorial (75)
Employer branding (21)
Employer resources (155)
Events (121116)
Executive appointments (1136)
FDA (20711)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1865)
Gene editing (248)
Generative AI (63)
Gene therapy (755)
GLP-1 (1103)
Government (4929)
Grass and pollen (7)
Guidances (421)
Healthcare (19245)
Hematology (192)
HIV (91)
Huntington's disease (62)
IgA nephropathy (113)
Immunology and inflammation (307)
Immuno-oncology (107)
Indications (222)
Infectious disease (3361)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (151)
Intellectual property (320)
Interviews (321)
IPO (16717)
IRA (51)
Job creations (3673)
Job search strategy (1436)
JPM (62)
Kidney cancer (21)
Labor market (112)
Layoffs (586)
Leadership (43)
Legal (8022)
Liver cancer (103)
Longevity (35)
Lung cancer (838)
Lymphoma (477)
Machine learning (65)
Management (61)
Manufacturing (1172)
Marketing (4)
MASH (211)
Medical affairs (1)
Medical device (14003)
Medtech (14177)
Mergers & acquisitions (20394)
Metabolic disorders (1671)
mRNA (263)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (462)
Neuropsychiatric disorders (112)
Neuroscience (3491)
Neurotech (1)
NextGen: Class of 2026 (6543)
Non-profit (4563)
Now hiring (83)
Obesity (773)
Opinion (301)
Ovarian cancer (241)
Pain (266)
Pancreatic cancer (354)
Parkinson's disease (395)
Partnered (36)
Patents (646)
Patient recruitment (774)
Peanut (67)
People (60220)
Pharmaceutical (55)
Pharmacy benefit managers (33)
Phase 1 (22601)
Phase 2 (31769)
Phase 3 (23622)
Pipeline (9909)
Policy (352)
Postmarket research (2623)
Preclinical (9606)
Press Release (66)
Prostate cancer (336)
Psychedelics (62)
Radiopharmaceuticals (346)
Rare diseases (1196)
Real estate (6029)
Recruiting (71)
Regulatory (26138)
Reports (56)
Research institute (2462)
Resumes & cover letters (354)
Rett syndrome (46)
RNA editing (29)
RSV (99)
Schizophrenia (183)
Series A (317)
Series B (234)
Service/supplier (11)
Sickle cell disease (121)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3675)
State (2)
Stomach cancer (18)
Supply chain (137)
Tariffs (90)
The Weekly (87)
Vaccines (1332)
Venture capital (124)
Weight loss (494)
Women's health (138)
Worklife (21)
Date
Today (43)
Last 7 days (480)
Last 30 days (2246)
Last 365 days (30475)
2026 (16459)
2025 (30310)
2024 (35292)
2023 (40216)
2022 (51368)
2021 (56038)
2020 (54405)
2019 (46656)
2018 (35133)
2017 (32276)
2016 (31695)
2015 (37733)
2014 (31531)
2013 (26569)
2012 (28795)
2011 (29527)
2010 (27721)
Location
Africa (793)
Alabama (93)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (40496)
Australia (6653)
California (14057)
Canada (3977)
China (1501)
Colorado (602)
Connecticut (613)
Delaware (437)
Europe (87886)
Florida (2119)
Georgia (448)
Hawaii (3)
Idaho (63)
Illinois (1156)
India (99)
Indiana (633)
Iowa (26)
Japan (603)
Kansas (135)
Kentucky (52)
Louisiana (58)
Maine (76)
Maryland (1686)
Massachusetts (10073)
Michigan (377)
Minnesota (762)
Mississippi (6)
Missouri (149)
Montana (36)
Nebraska (31)
Nevada (150)
New Hampshire (84)
New Jersey (3677)
New Mexico (30)
New York (3697)
North Carolina (1772)
North Dakota (11)
Northern California (7110)
Ohio (420)
Oklahoma (23)
Oregon (41)
Pennsylvania (2790)
Puerto Rico (31)
Rhode Island (52)
South America (1132)
South Carolina (87)
South Dakota (2)
Southern California (5577)
Tennessee (231)
Texas (2256)
United States (49597)
Utah (418)
Vermont (2)
Virginia (345)
Washington D.C. (82)
Washington State (1117)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
739,860 Results for "meissa vaccines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
COVID-19
FDA assembles vaccine experts to update COVID-19 formulation
The FDA will convene its vaccines advisory panel to discuss seasonal COVID-19 vaccines—a surprise move after Health Secretary and vaccine skeptic Robert F. Kennedy, Jr. overhauled a separate vaccine committee.
May 27, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Moderna partners with CEPI on Ebola vaccine efforts amid outbreak in Africa
Riding a newfound surge of interest on infectious disease concerns, Moderna is linking up with a global vaccine foundation in hopes of developing a vaccine to slow the new surge in Ebola underway in the Congo and Uganda.
June 1, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
KyooBe Tech Advances New Method for Vaccine Development
Leinfelden, Germany. Recent infectious disease events—from hantavirus outbreaks and meningitis cases to recurring disease outbreaks in livestock farming—highlight the need for flexibly scalable vaccine manufacturing processes. To address this challenge, Stuttgart-based technology company KyooBe Tech has developed a platform designed to accelerate vaccine production. This technology is now also available to external users for studies at the Fraunhofer Institute for Cell Therapy and Immunology (IZI).
June 30, 2026
·
1 min read
Sponsored by Sino Biological
Advances in RSV Vaccine Research and Development
Epidemiology, Next-Generation Vaccine Platforms, and the Critical Role of Prefusion F Antigens in RSV Research
May 11, 2026
·
7 min read
Biotech Bay
Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine Designed to Protect Infants and Toddlers
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced positive safety and immunogenicity data for MV-012-968, Meissa’s intranasal live attenuated RSV vaccine candidate, from a clinical study in RSV-naïve (seronegative) participants between the ages of six and 36 months.
August 8, 2023
·
4 min read
Mergers & Acquisitions
Lilly lands vaccine trifecta with 3 new biotech buys valued at up to $3.8B
Eli Lilly, with a busier-than-ever business development team, has made a major vaccine play‚ months after hiring veteran vaccine regulator Peter Marks following his FDA departure.
May 26, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
June 8, 2026
·
14 min read
mRNA
ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival
When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in a mid-stage trial of advanced melanoma—a result analysts said could help “instill confidence” in the regimen.
June 2, 2026
·
2 min read
·
Tristan Manalac
COVID-19
FDA’s own report shows no child deaths definitively caused by COVID vaccination
Despite having no definitive data, Sen. Ron Johnson (R-WI) in a letter to health secretary Robert F. Kennedy, Jr. suggested there was a conscious effort by the Biden administration’s FDA to cover up the safety risks of COVID-19 vaccines.
May 19, 2026
·
3 min read
·
Tristan Manalac
Earnings
GSK’s Shingrix strategy shift drives sales beat even as vaccines slow
While sales for most of GSK’s shots slumped as vaccine skepticism continues to climb in the U.S., Shingrix jumped 20% to almost $1.4 billion in the first quarter, emerging as the pharma’s top-selling product.
April 29, 2026
·
2 min read
·
Tristan Manalac
1 of 73,986
Next